The objective of this study was to evaluate the female sexual function in relation to hormonal status in pre-and postmenopausal women with obstructive sleep apnea (OSA). A total of 43 premenopausal (mean age 42.1±4.9) and 58 postmenopausal (mean age 59.9±4.8) women were included in the study. All women filled out the Epworth sleepiness scale (ESS), the Beck Depression Inventory (BDI) and the Female Sexual Function Index (FSFI). Testosterone, estradiol and progesterone were measured. After polysomnography, women were allocated to a not-severe OSA group (Apnea--Hypopnea Index (AHI) 10--30) and a severe OSA group (AHI 430). Healthy subjects comprised the control group. Severe OSA women in both pre-and post-menopausal group were found to have significantly lower mean FSFI score (16.5 ± 4.0 and 16.9 ± 4.7, respectively) compared with not-severe OSA (23.4 ± 5.5, Po0.01 and 21.8 ± 7.5, Po0.05) and control subjects (27.0 ± 5.5, Po0.01 and 24.0±6.7, Po0.01). Progesterone, which was significantly lower in severe OSA premenopausal women (0.26±0.2) compared with not-severe OSA (0.55 ± 0.14, Po0.01) and control group (0.62 ± 0.16, Po0.01), correlated significantly with FSFI (r ¼ 0.39, Po0.01). Our study demonstrated that OSA is associated with sexual dysfunction in both premenopausal and postmenopausal women in a dose-related fashion. Regarding premenopausal women, our results indicated that progesterone may play a role in the association between OSA and female sexual dysfunction.
INTRODUCTION
Obstructive sleep apnea (OSA) is a clinical entity that was recognized more than 30 years ago. 1 The results of several studies have shown that this is a very common problem with significant consequences on the health of the patients. 2--4 There is a strong male preponderance as OSA affects B4% of male and 2% of female adults. 2, 5 The role of hormones in the pathogenesis of the disease explains to some extent the difference in the two sexes. 6 Furthermore, hormone changes explain the fact that postmenopausal women are more likely to develop OSA compared with premenopausal women. 6, 7 The association between sexual dysfunction (SD) and obstructive sleep apnea in men has been studied thoroughly and has been confirmed by many studies published since the late 1970s. 8--12 Unlike men, there have been very few studies concerning women and all reports agree that OSA is associated with SD. 13--16 The objective of our study is to determine the association between OSA, sexual function and hormonal profile in pre-and post-menopausal women.
PATIENTS AND METHODS Patients
This study was a collaboration between Urology and Pneumonology Department and was approved by the institutional ethics committee. Between March 2008 and May 2010, a total number of 249 patients were evaluated for OSA. All patients were informed and provided a signed consent in order to participate in our study. In all cases a detailed sleep and past medical history was received. Daytime sleepiness was estimated by filling out the Epworth Sleepiness Scale (ESS). 17 Exclusion criteria were history of alcohol or other substances abuse, severe cardiac or pulmonary disease, uncontrolled hypertension, diabetes mellitus, thyroid diseases, history of medication usage with sexual side effects such as psychotropic medications and oral contraceptives, severe pelvic organ prolapse, perimenopause and the absence of a regular heterosexual relationship. Perimenopausal women were considered those aged between 45 and 55 years. 18 A total of 101 patients met the inclusion criteria. Among them, 43 (43.0%) were premenopausal (mean age 42.1 ± 4.9 years) and 58 (57.0%) were postmenopausal (mean age 59.9 ± 4.8 years).
Questionnaire
The Female Sexual Function Index (FSFI) is a brief, 19-item self-report questionnaire for the assessment of female sexual dysfunction (FSD) including disorders of desire, libido, arousal, pain/discomfort and inhibited orgasm. 19 An FSFI total score of o26.55 is suggestive of SD. 20 Patients were also asked to fill out Beck Depression Inventory (BDI), a 21-item, selfreport inventory, which is an instrument for measuring clinical depression and scores range from 0 to 63. 21 Higher scores indicate higher level of depressive symptoms. 22 Hormone measurements Progesterone (PRG), estradiol and total testosterone were measured in day 3 (follicular phase) in case of cycling women and a random day in postmenopausal women. All blood samples were obtained mid-morning to allow direct comparisons of diurnally variant hormonal production.
Polysomnography
All patients underwent a full-night polysomnography, which included continuous recording of oronasal flow, thoracoabdominal movement, electrocardiography, submental and pretibial electromyography, electrooculography, electroencephalography and arterial oxygen saturation (Alice 4 Diagnostic Device OBS/G7829, Respironics, Marietta, GA, USA). Sleep data and respiratory events were scored according to standard criteria. 23, 24 Female patients aged 420 years who underwent full-night polysomnography and were diagnosed with OSA with at least 10 apneas or hypopneas per sleep hour were considered eligible for entry. Subjects diagnosed without OSA after polysomnography (Apnea--Hypopnea Index (AHI) Score o10) were recruited to comprise the control group of the study. In all, 17 (39%) premenopausal and 41 (70%) postmenopausal women were diagnosed with OSA after polysomnography. Minimum oxygen saturation (MinSat) and Oxygen Desaturation Index (ODI) were also determined in all cases.
Study design
Pre-and post-menopausal women were allocated into two separate groups. The subjects were further classified according to the presence and severity of OSA as having no OSA (control group AHI o10), not-severe OSA (AHI 10--30) and severe OSA (AHI 430). No statistically significant difference was found in the incidence of smoking habits, hypertension, coronary disease or hyperlipidemia between OSA severity groups and control group.
Statistical analysis
All data were entered into SPSS (version 12.0, SPSS Inc., Chicago, IL, USA). Continuous variables were expressed as mean ± s.d. Mann--Whitney U-test and Kruskal--Wallis test were used to compare the medians among groups. Pearson's correlation coefficients were calculated to clarify the relationship between FSFI and its domains with AHI, MinSat, ODI, ESS, body mass index (BMI) and BDI. Additional partial correlation analysis, controlling for age and BMI, was carried out. In order to estimate the coefficients among several independent variables (age, AHI, BDI and BMI) that best predict the value of FSFI, multiple logistic regression analyses were used. For all comparisons, Po0.05 was considered statistically significant.
RESULTS
The mean age, BMI, ESS, MinSat, AHI, ODI, BDI and FSFI parameters for all patients according to the groups are given in Table 1 .
In premenopausal group, SD as determined by an FSFI total score of o26.55 was diagnosed in 8 (100%) women with severe OSA, in 6 (67%) women from the not-severe OSA group and in 12 (46%) women without OSA. The rate of SD differed significantly between severe OSA and control group (Po0.01). In postmenopausal group, SD occurred at a higher rate among severe OSA women (22 cases, 96%) compared with control group (7 cases, 41%) and this difference was statistically significant (Po0.01). In not-severe OSA women, SD was found in 13 (72%) cases.
The mean FSFI and sexual domain scores for each group are given in Table 2 . In pre-and post-menopausal group, severe OSA women were found to have significant lower FSFI scores (16.5±4.0 and 16.9±4.7, respectively) compared with not-severe OSA women (23.4 ± 5.5, Po0.01 and 21.8 ± 7.5, Po0.05, respectively) and control group (27.0 ± 5.5, Po0.01 and 24.0 ± 6.7, Po0.01, respectively).
In premenopausal women there was also a significant negative correlation between FSFI and AHI before and after controlling for age and BMI (r ¼ À0.61, Po0.01 and r ¼ À0.45, Po0.05, respectively; Table 3 ). Furthermore, all FSFI domains correlated significantly with AHI, MinSat and ODI except for the domain of desire after controlling for age and BMI (Table 3 ). In postmenopausal women, FSFI correlated significantly only with ODI after controlling for age and BMI (r ¼ À0.30, Po0.05). Table 1 . Baseline characteristics of OSA patients and control subjects Moreover, there was a significant negative correlation between BDI and FSFI in pre-and post-menopausal women (r ¼ À0.52, Po0.01 and r ¼ À0.38, Po0.01, respectively), whereas with regard to the three OSA groups, there was no significant difference in terms of BDI.
Multiple logistic regression analysis showed that AHI was the most significant independent determinant of FSFI in premenopausal women. It also indicated age and AHI as the most significant independent determinants in postmenopausal women.
Hormonal levels of all patients were given in Table 4 . In premenopausal women, the mean PRG levels (0.26 ± 0.20) in severe OSA group were significantly lower compared with notsevere OSA (0.55±0.14, Po0.01) and control group (0.62±0.16, Po 0.01). Moreover, a significant difference between severe OSA Table 4 ). Table 5 shows the correlations between baseline hormone levels and FSFI. Significant relationship was found between FSFI and PRG in premenopausal women (r ¼ 0.23, Po0.05), as well as between FSFI and estrogen in postmenopausal women (r ¼ 0.32, Po0.05) after controlling for age and BMI.
DISCUSSION
Our study demonstrated that premenopausal women with severe OSA were more likely to have SD compared with control and notsevere OSA women, indicating that there is an association between severity of OSA and SD. We also demonstrated a statistically significant negative correlation between AHI and FSFI that remained after controlling for the effects of age and BMI. Similar to the premenopausal women, our results showed that postmenopausal women with severe OSA were found to have worse sexual function compared with women in not-severe OSA and control group. With regard to hormones we showed that PRG may play a role in the association between OSA and FSD in premenopausal women.
Our results were consistent with those of previous studies, which investigated the relationship between OSA and female sexual function. Koseoglu et al., 13 in 2007, were the first to study the correlation of sexual function in women with OSA. They analyzed 25 premenopausal OSA women and found a significant negative correlation between OSA and sexual function, which was evaluated using the Sexual Function Questionnaire Version 2 (SFQ-V2). Their results showed that RDI correlated significantly with all domains of sexual function except for pain and enjoyment. Among the other parameters related to OSA, they found a significant correlation between ESS and all domains except for orgasm, pain and enjoyment. MinSat was significantly correlated only with orgasm. Of note, ESS is a subjective and less accurate indicator of OSA compared with AHI, MinSat and ODI, which are the basic measures of sleep performance. Except for ESS, our study demonstrated a significant correlation between AHI, MinSat, ODI and all sexual domains, thereby further confirming the association between OSA and FSD.
In accordance with the aforementioned study, Onem et al. 14 found that OSA is associated with SD in women, although the severity of OSA is not related to the degree of SD. Our results, on the contrary, showed that there is an association between severity of OSA and SD. Onem et al.
14 revealed that only desire, orgasm and satisfaction in mild OSA women as well as desire and lubrication in moderate/severe OSA women were significantly lower compared with control subjects.
14 With regard to variables related to OSA, they demonstrated a significant correlation between AHI, MinSat and FSFI as well as between AHI, arousal and lubrication in particular. In our study, in addition to AHI and MinSat, we found a significant negative correlation between FSFI and ODI, which strengthens the relationship between OSA and FSD.
Subramanian et al. 15 compared 21 OSA women with 11 healthy subjects and they confirmed the high prevalence of SD in women with OSA. Although not for overall FSFI, they found a significant correlation only between sexual arousal and RDI.
Recently, Petersen et al. 16 investigated 80 OSA women (ages 28--64 years). They found that OSA women have an increased prevalence of sexual difficulties and sexual-related distress compared with women without OSA, although SD was not related to severity of OSA. However, they included perimenopausal women, contrary to our study in which they were excluded in order to have more clear results especially with regard to hormones. It is well known that additional factors such as mood depression are involved in SD. 25, 26 Furthermore, the results of many studies have indicated a high prevalence of depression in OSA population, resulting in a more confusing relationship between OSA and SD. 27--29 In our study, BDI was not significantly different between the three OSA groups, presumably because of the fact that OSA and depression have certain symptoms that are common to both disorders. 30, 31 Many patients who were referred to the sleep laboratory suffering from symptoms like fatigue, sleepiness and anxiety did not present any polysomnographic features of OSA, and these patients formed the control group. Therefore, our control group was healthy according to the AHI score and not according to OSA-like symptoms. The fact that the BDI was not statistically different between groups makes our results more definite. Meanwhile, our results confirmed the literature regarding the relationship between SD and depression demonstrating that there was a significant negative correlation between BDI and FSFI. 25, 26 Onem et al.
14 agreed with our results by finding that BDI was an independent predictor factor for desire and satisfaction, whereas Subramanian et al. 15 could not find any correlation between depressed mood and FSFI. 14, 15 With regard to postmenopausal women, we found that FSFI in severe OSA group was significant lower compared with not-severe OSA and control group. We also demonstrated a significant negative correlation between AHI, MinSat, ODI and FSFI. This correlation remained significant only for ODI and FSFI after controlling for age and BMI, implying that the association between OSA and FSFI in postmenopausal women is more complicated and multifactorial. With reference to sleepiness, there was a significant correlation between ESS and the sexual domains except for lubrication and pain. Similar to FSFI, our results showed that the domains of sexual function except for arousal are indirectly associated with AHI and mediated probably by age and BMI. This is in agreement with several previous studies, which suggest that as women age they experience a decline in sexual function. 32--34 In aging women all domains of sexual function may be affected, although most reports agree that the most common dysfunctions are decline in desire and decreased distress about sex. Several changes occur with age and potentially affect female sexual function. These changes become more pronounced during and after menopausal transition. 35, 36 The normal sexual response can be altered by a change in central or peripheral physiology because of several diseases. 37 Concurrent medical illnesses such as cardiopulmonary, endocrine (especially diabetes) and neurological diseases as well as arthritis affects mobility, functional ability and tolerance to physical activity, reduces sexual desire, influences body image and perceived attractiveness and lowers women's self-esteem. SD in the aging women may also result from relationship-relative reasons, such as duration of relationship, lack of sexual communication, availability of a partner and health problems, especially the sexual health of the partner. 32 Psychological factors such as depression are very common in aging, menopausal women and are associated with SD. With regard to the hormonal status, the decline of estrogen, which commences with menopause, and the reduced testosterone levels in postmenopausal women cause physical changes that may affect sexual function. 38--40 Several studies have demonstrated hormonal abnormalities in patients with OSA, indicating a potential risk factor for FSD. 6, 41 Sleep fragmentation and disturbance of sleep cycles, the increased level of stress hormones due to overnight arousals, the alterations in the hypothalamo--pituitary axis caused by hypoxia's direct effect on central neurotransmitters, the hypercapnia and, finally, the sleep-controlled endocrine rhythms disturbance due to disorganization of sleep, sleep loss and naps altogether result in endocrine abnormalities in patients with OSA. 6, 42 When determining hormonal status in premenopausal women, our results showed a significant PRG level decrease in severe OSA group compared with not-severe OSA and control subjects, confirming previous studies. 6, 41 Several studies have showed the stimulatory effect of PRG on breathing. 6, 43 Hyperventilation and low CO 2 during pregnancy and luteal phase of menstrual cycle were explained by high levels of PRG. 6, 43 Although less is known about the influence of PRG in female sexual function, we found a significant positive correlation between PRG and FSFI score, indicating a potential role in the association between OSA and FSD. 44 This correlation remained significant in all FSFI domains except for desire and satisfaction. In agreement with literature, we found significant lower levels of serum estradiol in severe OSA women when compared with control subjects. 6 With regard to postmenopausal women, our results showed that PRG level was significant lower in severe OSA women compared with not-severe OSA and control group. In contrast to premenopausal women, there was no correlation between PRG and FSFI, suggesting that this potent respiratory stimulant hormone seems to play no role in SD in postmenopausal women. As it was expected, a significant and fairly strong positive correlation was found between estrogen and FSFI score, as well as between estrogen and all domains of sexual function except for satisfaction. After controlling for age, this correlation remained significant only for arousal, lubrication, orgasm and pain, indicating that other factors related to age affect sexual desire and satisfaction.
A potential limitation of our study was the small size of each group as well as the fact that the patients groups were not similar regarding the BMI. Another potential limitation is that we measured the PRG levels on day 3 (follicular phase) in case of premenopausal women, and thus our results do not reflect the peak levels of PRG.
In conclusion, our study clearly showed that pre-and postmenopausal women with severe OSA had worse sexual function compared with control and not-severe OSA subjects. In postmenopausal women, additional factors such as age and BMI appear to be involved in SD, thus underlining the complexity of sexual function in the aging woman. According to our results, PRG may play a role in the association between OSA and FSD in premenopausal woman, although additional studies are required to further evaluate the role of PRG.
